Alternate-day dornase alfa acceptable in cystic fibrosis

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1311, 2001-01, pp. : 14-14

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Alternate day dornase alfa acceptable in cystic fibrosis

By  

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 336, 2001-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Ovulation induction with tamoxifen and alternate-day gonadotrophin in patients with thin endometrium

By Wang Chia-Woei   Horng Shang-Gwo   Chen Chun-Kai   Wang Hsin-Shih   Huang Hong-Yuan   Lee Chyi-Long   Soong Yung-Kuei  

Reproductive BioMedicine Online, Vol. 17, Iss. 1, 2008-07 ,pp. : 20-26

Reproductive Healthcare Ltd

Access to resources Recommend Favorite

Dornase alfa shows promise for treating critical lung atelectasis and mucus plugging

By  

Inpharma, Vol. 1, Iss. 1308, 2001-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite

Drug Disposition in Cystic Fibrosis

By Rey E.   Tréluyer J-M.   Pons G.  

Clinical Pharmacokinetics, Vol. 35, Iss. 4, 1998-10 ,pp. : 313-329

Adis International

Access to resources Recommend Favorite

Nebulized Antibiotics in Cystic Fibrosis

By Sermetgaudelus I.  

Pediatric Drugs, Vol. 4, Iss. 7, 2002-01 ,pp. : 455-467

Adis International

Access to resources Recommend Favorite